Filing Details

Accession Number:
0001628280-23-020720
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-02 19:15:36
Reporting Period:
2023-06-02
Accepted Time:
2023-06-02 19:15:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576263 Mirati Therapeutics Inc. MRTX Pharmaceutical Preparations (2834) 462693615
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1644348 Laurie Stelzer C/O Mirati Therapeutics, Inc
3545 Cray Court
San Diego CA 92121
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-02 4,647 $37.06 80,015 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on June 01, 2022.